<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 19 May 2026 17:08:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  10-Q       ORAMED PHARMACEUTICALS    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26522496.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26522496.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26522496.html</guid>
   <pubDate>Tue, 19 May 2026 17:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  10-Q       ORAMED PHARMACEUTICALS    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26522496.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26522496.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26522496.html</guid>
   <pubDate>Tue, 19 May 2026 17:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    ORAMED PHARMACEUTICALS    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26505143.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26505143.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26505143.html</guid>
   <pubDate>Fri, 15 May 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    ORAMED PHARMACEUTICALS    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26505143.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26505143.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+31/26505143.html</guid>
   <pubDate>Fri, 15 May 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  ORAMED PHARMACEUTICALS                 Filed by: Aquamarine Financial (Cayman) Ltd</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Aquamarine+Financial+%28Cayman%29+Ltd/26502586.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26502586.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Aquamarine+Financial+%28Cayman%29+Ltd/26502586.html</guid>
   <pubDate>Fri, 15 May 2026 12:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  ORAMED PHARMACEUTICALS                 Filed by: Aquamarine Financial (Cayman) Ltd</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Aquamarine+Financial+%28Cayman%29+Ltd/26502586.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26502586.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+Aquamarine+Financial+%28Cayman%29+Ltd/26502586.html</guid>
   <pubDate>Fri, 15 May 2026 12:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  8-K        ORAMED PHARMACEUTICALS    For: Mar 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+25/26251295.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26251295.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+25/26251295.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  8-K        ORAMED PHARMACEUTICALS    For: Mar 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+25/26251295.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26251295.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+25/26251295.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 30  Filed by: KIDRON NADAV</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+KIDRON+NADAV/26250919.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26250919.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+KIDRON+NADAV/26250919.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 30  Filed by: KIDRON NADAV</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+KIDRON+NADAV/26250919.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26250919.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+KIDRON+NADAV/26250919.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 30  Filed by: Kidron Miriam</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+Kidron+Miriam/26250912.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26250912.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+Kidron+Miriam/26250912.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 30  Filed by: Kidron Miriam</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+Kidron+Miriam/26250912.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26250912.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+30++Filed+by%3A+Kidron+Miriam/26250912.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  10-K       ORAMED PHARMACEUTICALS    For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++ORAMED+PHARMACEUTICALS++++For%3A+Dec+31/26225730.html</link>
   <description>si-local-file:///var/storage/secattach/20260326/26225730.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++ORAMED+PHARMACEUTICALS++++For%3A+Dec+31/26225730.html</guid>
   <pubDate>Thu, 26 Mar 2026 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  10-K       ORAMED PHARMACEUTICALS    For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++ORAMED+PHARMACEUTICALS++++For%3A+Dec+31/26225730.html</link>
   <description>si-local-file:///var/storage/secattach/20260326/26225730.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++ORAMED+PHARMACEUTICALS++++For%3A+Dec+31/26225730.html</guid>
   <pubDate>Thu, 26 Mar 2026 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward closes strategic partnership with Oramed</title>
   <link>http://www.streetinsider.com/Corporate+News/Lifeward+closes+strategic+partnership+with+Oramed/26217306.html</link>
   <description>

&lt;p&gt;Lifeward Ltd. (NASDAQ: LFWD) announced it has completed its strategic partnership agreement with Oramed Pharmaceuticals Inc. (NASDAQ: ORMP). The medical technology company acquired Oramed's clinical-stage Protein Oral Delivery technology through the transaction.&lt;/p&gt;

&lt;p&gt;The partnership provides Lifeward with access to up to $47 million in capital from Oramed and certain investors. On March 25, 2026, Lifeward accessed $10 million of this capital, according to the company's statement.&lt;/p&gt;

&lt;p&gt;Lifeward develops medical technology solutions for people with physical limitations or disabilities. The company's product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit.&lt;/p&gt;

&lt;p&gt;The company has made changes to its board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Lifeward+closes+strategic+partnership+with+Oramed/26217306.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:11 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward closes strategic partnership with Oramed</title>
   <link>http://www.streetinsider.com/Corporate+News/Lifeward+closes+strategic+partnership+with+Oramed/26217306.html</link>
   <description>

&lt;p&gt;Lifeward Ltd. (NASDAQ: LFWD) announced it has completed its strategic partnership agreement with Oramed Pharmaceuticals Inc. (NASDAQ: ORMP). The medical technology company acquired Oramed's clinical-stage Protein Oral Delivery technology through the transaction.&lt;/p&gt;

&lt;p&gt;The partnership provides Lifeward with access to up to $47 million in capital from Oramed and certain investors. On March 25, 2026, Lifeward accessed $10 million of this capital, according to the company's statement.&lt;/p&gt;

&lt;p&gt;Lifeward develops medical technology solutions for people with physical limitations or disabilities. The company's product portfolio includes the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit.&lt;/p&gt;

&lt;p&gt;The company has made changes to its board</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Lifeward+closes+strategic+partnership+with+Oramed/26217306.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:11 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward Successfully Closes on Strategic Partnership with Oramed</title>
   <link>http://www.streetinsider.com/Press+Releases/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</link>
   <description>&lt;p align=&quot;justify&quot; style=&quot;text-align: justify;&quot;&gt;  &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT, Israel, March  25, 2026  (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The transaction has positioned Lifeward as a diversified biomedical innovation company with an expected clear path to profitability. Lifeward acquired Oramed’s clinical-stage Protein Oral Delivery (POD™) technology, adding exposure to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward Successfully Closes on Strategic Partnership with Oramed</title>
   <link>http://www.streetinsider.com/Press+Releases/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</link>
   <description>&lt;p align=&quot;justify&quot; style=&quot;text-align: justify;&quot;&gt;  &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT, Israel, March  25, 2026  (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The transaction has positioned Lifeward as a diversified biomedical innovation company with an expected clear path to profitability. Lifeward acquired Oramed’s clinical-stage Protein Oral Delivery (POD™) technology, adding exposure to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward Successfully Closes on Strategic Partnership with Oramed</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</link>
   <description>&lt;p align=&quot;justify&quot; style=&quot;text-align: justify;&quot;&gt;  &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT, Israel, March  25, 2026  (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The transaction has positioned Lifeward as a diversified biomedical innovation company with an expected clear path to profitability. Lifeward acquired Oramed’s clinical-stage Protein Oral Delivery (POD™) technology, adding exposure to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Lifeward Successfully Closes on Strategic Partnership with Oramed</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</link>
   <description>&lt;p align=&quot;justify&quot; style=&quot;text-align: justify;&quot;&gt;  &lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT, Israel, March  25, 2026  (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The transaction has positioned Lifeward as a diversified biomedical innovation company with an expected clear path to profitability. Lifeward acquired Oramed’s clinical-stage Protein Oral Delivery (POD™) technology, adding exposure to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Lifeward+Successfully+Closes+on+Strategic+Partnership+with+Oramed/26217302.html</guid>
   <pubDate>Wed, 25 Mar 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 17  Filed by: Kidron Miriam</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Kidron+Miriam/26186649.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26186649.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Kidron+Miriam/26186649.html</guid>
   <pubDate>Wed, 18 Mar 2026 17:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 17  Filed by: Kidron Miriam</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Kidron+Miriam/26186649.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26186649.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Kidron+Miriam/26186649.html</guid>
   <pubDate>Wed, 18 Mar 2026 17:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 17  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Gabay+Avraham/26186636.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26186636.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Gabay+Avraham/26186636.html</guid>
   <pubDate>Wed, 18 Mar 2026 17:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 17  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Gabay+Avraham/26186636.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26186636.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Gabay+Avraham/26186636.html</guid>
   <pubDate>Wed, 18 Mar 2026 17:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Form  4          ORAMED PHARMACEUTICALS    For: Mar 17  Filed by: Hexter Joshua</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Hexter+Joshua/26186641.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26186641.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Mar+17++Filed+by%3A+Hexter+Joshua/26186641.html</guid>
   <pubDate>Wed, 18 Mar 2026 17:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
 </channel>
</rss>
